Answers are grounded in this paper and cite their sources.
Resurgence of Bordetella pertussis in recent years in the United States has coincided with a dramatic rise in pertactin-deficient strains. Limited data exist on detectability by nucleic acid amplification testing and antimicrobial susceptibility of pertactin-deficient B. pertussis. This study compares 15 pertactin-producing and 15 pertactin-deficient B. pertussis isolates. Pertactin-producing and pertactin-deficient strains were equally detected by nucleic acid amplification testing and were susceptible to antibiotics.
No takes yet. Share an insight, caveat, or question.
Souder et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: